REVIEW OF THE COURSE AND TREATMENT FEATURES OF COVID-19 PATIENTS WITH CONCOMITANT CARDIOVASCULAR DISEASE
Khusinova Shoira AkbarovnaSamarkand State Medical University, Republic of Uzbekistan, SamarkandRakhimova Khidoyat Mamarasulovna,Samarkand State Medical University, Republic of Uzbekistan, SamarkandKhakimova Leyla RafikovnaSamarkand State Medical University, Republic of Uzbekistan, SamarkandYuldashova Nadira Egamberdievna,Samarkand State Medical University, Republic of Uzbekistan, SamarkandAbduxamidova Dilshoda KhalimovnaSamarkand State Medical University, Republic of Uzbekistan, Samarkand
ABI
Annotatsiya
Abstract: Purpose The aim of the study was to develop proposals and recommendations to improve the diagnosis and treatment of patients with Covid-19 with concomitant cardiovascular pathology. Age and cardiovascular comorbidities are independent factors in mortality and intensive care unit hospitalization in patients with COVID-19. The high prevalence of arterial hypertension (AH) in older people with coronary or heart failure explains the high prevalence of hypertension among patients hospitalized with severe COVID-19. As a leading risk factor for cardiovascular disease, hypertension is a bedrock of cardiovascular comorbidities that contributes to the development of severe forms of COVID-19.
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba